Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00RNA
|
|||
Former ID |
DNC008112
|
|||
Drug Name |
N-hydroxy-3-(2-oxo-2H-chromen-3-yl)propanamide
|
|||
Synonyms |
CHEMBL252674; N-hydroxy-3-(2-oxo-2H-chromen-3-yl)propanamide; 2H-1-Benzopyran-3-propanamide, N-hydroxy-2-oxo-; BDBM50224963
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C12H11NO4
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C=C(C(=O)O2)CCC(=O)NO
|
|||
InChI |
1S/C12H11NO4/c14-11(13-16)6-5-9-7-8-3-1-2-4-10(8)17-12(9)15/h1-4,7,16H,5-6H2,(H,13,14)
|
|||
InChIKey |
HJRCGMHZQDXQAO-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation. Bioorg Med Chem. 2008 Jan 1;16(1):530-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.